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Abstract
Mutations affecting the ribosome lead to several diseases known as ribosomopathies, with phenotypes that include growth
defects, cytopenia, and bone marrow failure. Diamond-Blackfan anemia (DBA), for example, is a pure red cell aplasia linked
to the mutation of ribosomal protein (RP) genes. Here we show the knock-down of the DBA-linked RPS19 gene induces the
cellular self-digestion process of autophagy, a pathway critical for proper hematopoiesis. We also observe an increase of
autophagy in cells derived from DBA patients, in CD34
+ erythrocyte progenitor cells with RPS19 knock down, in the red
blood cells of zebrafish embryos with RP-deficiency, and in cells from patients with Shwachman-Diamond syndrome (SDS).
The loss of RPs in all these models results in a marked increase in S6 kinase phosphorylation that we find is triggered by an
increase in reactive oxygen species (ROS). We show that this increase in S6 kinase phosphorylation inhibits the insulin
pathway and AKT phosphorylation activity through a mechanism reminiscent of insulin resistance. While stimulating RP-
deficient cells with insulin reduces autophagy, antioxidant treatment reduces S6 kinase phosphorylation, autophagy, and
stabilization of the p53 tumor suppressor. Our data suggest that RP loss promotes the aberrant activation of both S6 kinase
and p53 by increasing intracellular ROS levels. The deregulation of these signaling pathways is likely playing a major role in
the pathophysiology of ribosomopathies.
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Introduction
Diseases linked to mutations affecting the ribosome include
inherited disorders such as Diamond-Blackfan anemia (DBA),
Shwachman-Diamond syndrome (SDS), and dyskeratosis con-
genita (DC) [1]. They may also be acquired as with 5q-
myelodysplastic syndrome (5q-MDS) [2]. While the phenotypes
of these disorders vary extensively in clinical features and severity,
the majority of them share some form of cytopenia. DBA, for
example, is a pure red cell aplasia linked predominantly to
mutations in ribosomal protein (RP) genes [3]. Patients with DBA
experience a block in erythroid progenitor cell division and
expansion in the bone marrow leading to the characteristic
erythroblastopenia [4,5]. Growth defects, which are routinely
observed in animal models of RP gene haploinsufficiency, are also
common clinical features of patients with DBA as well as SDS and
very severe forms of DC [6–10]. While it has been speculated that
the hematopoietic phenotype at least in DBA patients is linked to
the activation of the p53 tumor suppressor [11], the mechanistic
understanding of the pathophysiology underlying DBA and other
diseases linked to mutations affecting the ribosome remains
incompletely understood.
Autophagy is the highly conserved cellular process of self-
digestion that involves the formation of double-membrane
structures termed autophagosomes engulfing cytoplasmic proteins
and organelles [12]. These autophagosomes then fuse with
lysosomes to become autolysosomes, wherein the proteins and
organelles are degraded and then either recycled or exocytosed
PLOS Genetics | www.plosgenetics.org 1 May 2014 | Volume 10 | Issue 5 | e1004371[13]. Autophagy is commonly observed during times of nutrient
depletion or starvation and is up regulated in response to
oxidative stress or the presence of deleterious organelles and
protein aggregates [14]. Autophagy also plays a critical role in
erythrocyte maturation. Conditional knockout of Atg7,e s s e n t i a l
for the formation of the autophagosome membrane, yields
hematopoietic stem cell failure, erythrocyte cell death, and severe
anemia in mice due to the defective removal of mitochondria by
autophagy (mitophagy) [15]. Additionally, the targeted deletion
of the BCL-2 family member Nix results in defective erythroid
maturation through impaired mitophagy during terminal ery-
throid differentiation and also causes anemia in a murine model
[16].
The nutrient-sensitive AKT/target-of-rapamycin (TOR)
pathway plays a critical role in controlling cell growth and size
by stimulating the transcription of a number of factors required
for protein translation including RP genes [17,18]. TOR-
dependent autophagy induced by starvation or rapamycin
treatment occurs through decreasing the TOR-dependent
phosphorylation of Atg13, an event required for association of
A t g 1 3w i t hA t g 1a n ds u b s e q u e nt autophagosome formation
[19]. One important downstream effector of TOR signaling is
S6 kinase, whose substrates include the translation machinery
elements RPS6, eukaryotic initiation factor 4B (eIF4B), and
eukaryotic elongation factor 2 kinase (eEF2K) [20–22]. S6
kinase phosphorylation also promotes the formation of autop-
hagosomes, which in combination with the negative regulation
of autophagy by TOR provides a balance to prevent cells from
excessive self-digestion during prolonged periods of starvation
[23].
One of the many activators of AKT and TOR is a
phosphorylation cascade initiated by the stimulation of cells with
the extracellular growth factor insulin and signaling through the
insulin receptor substrate (IRS1) and PI3-kinase to promote the
turnover of PIP2 to PIP3 [24]. The highly conserved insulin
pathway is required for the cellular import of glucose, the most
vital carbohydrate for activation of the glycolysis pathway and the
generation of ATP. AKT activation is as effective as insulin
stimulation in inducing the expression of the glucose transporter 1
(GLUT1), the most highly expressed glucose transporter on
glycolysis-dependent erythrocytes, while in other cells such as
adipocytes insulin-activated AKT promotes the translocation of
GLUT4 to the plasma membrane to increase glucose import
[25,26]. Resistance of the insulin pathway to stimulation by
extracellular ligands can occur through the over activation of S6
kinase, that in turn directly phosphorylates IRS1 leading to its
degradation [27,28]. This mechanism of insulin resistance is
commonly found in obese individuals with type II diabetes, due in
large part to increased caloric intake and constitutive activation of
the TOR pathway and S6 kinase. A loss of insulin signaling is also
known to induce autophagy [29,30]. While insulin signaling can
repress autophagy through TOR phosphorylation of Atg13, a
TOR-independent mechanism of repression has been described
involving the AKT-dependent phosphorylation and functional
inhibition of beclin-1, the yeast homolog of Atg6, an important
initiator of autophagosome formation [31,32]. In this study we set
out to determine if the mechanism inducing autophagy from RP
loss is linked to the insulin pathway in a TOR-independent
manner.
Results
Knock down of RPS19 induces autophagy
RPS19 is the gene most commonly mutated in DBA patients [3].
We therefore selected siRNAs against RPS19 to study the effects of
its knock down in HEK cells stably expressing GFP-LC3, a widely
used reporter construct for measuring autophagy levels [33].
Figure 1A shows a western blot analysis of RPS19 expression in
GFP-LC3 cells transfected with siRPS19 or a scrambled siRNA
control (siScr) compared to the effects of treatment with 100 nM
rapamycin, an inhibitor of TOR that is known to decrease the
expression of RPs [18]. The quantification of Figure 1A in 1B
indicates that the level of RPS19 knock down obtained is
approximately 50%, equivalent to levels expected in DBA patients
with RPS19 haploinsufficiency. Knock down of RPS19 in GFP-
LC3 cells induces autophagy, as shown by western blot analysis
with an antibody that recognizes the 18 kD LC3-I and the 16 kD
LC3-II protein (Figure 1C). LC3-I is converted to LC3-II upon
autophagosome formation due to the conjugation of phosphati-
dylethanolamine (PE) that enables LC3-II to migrate faster on
SDS/PAGE gels, and comparing the levels of LC3-II to actin is a
reliable method to measure the level of autophagy [33]. The
formation of autophagosomes upon RPS19 knock down can also
be visualized by the increase of GFP-LC3 puncta found in the
cytoplasm of siRPS19 transfected cells compared to cells transfect-
ed with siScr (Figure 1D top panels and quantified in Figure 1E as
the number of puncta/cell, N.100, p=0.002). Bafilomycin A
(bafA) is a drug that inhibits vacuolar H+ ATPase and is
commonly used to block the fusion of autophagosomes with
autolysosomes [34]. The lower left panel of Figure 1D shows a
marked increase in autophagosome formation in GFP-LC3 HEK
cells transfected with siScr and treated with bafA as compared to
untreated cells, indicating a high degree of steady-state autophagic
flux in normal HEK cells. However, a large amount of GFP-LC3
remains cytoplasmic. In cells transfected with siRPS19 and treated
with bafA (Figure 1D, lower right panel) the cytoplasmic GFP-
LC3 is almost completely gone and practically all the GFP-LC3 is
distributed in a puncta fashion, indicating localization in
autophagosomes and/or autolysosomes (quantified in Figure 1F
as the percent of cells with cytoplasmic GFP). We confirmed the
presence of these structures by immuno-electron microscopy of
HEK cells with reduced levels of RPS19 (Figure 1G). These
micrographs reveal autolysosomes that contain degraded organ-
Author Summary
Diseases linked to mutations affecting the ribosome,
ribosomopathies, have an exceptionally wide range of
phenotypes. However, many ribosomopathies have some
features in common including cytopenia and growth
defects. Our study aims to clarify the mechanisms behind
these common phenotypes. We find that mutations in
ribosomal protein genes result in a series of aberrant
signaling events that cause cells to start recycling and
consuming their own intracellular contents. This basic
mechanism of catabolism is activated when cells are
starving for nutrients, and also during the tightly regulated
process of blood cell maturation. The deregulation of this
mechanism provides an explanation as to why blood cells
are so acutely affected by mutations in genes that impair
the ribosome. Moreover, we find that the signals activating
this catabolism are coupled to impairment of the highly
conserved insulin-signaling pathway that is essential for
growth. Taken together, our in-depth description of the
pathways involved as the result of mutations affecting the
ribosome increases our understanding about the etiology
of these diseases and opens up previously unknown
avenues of potential treatment.
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presence of LC3 using immuno-gold labeling (right panel).
Because DBA-linked mutations in RPS19 primarily affect the
function of CD34
+ erythroid progenitor cells in humans, we
infected CD34
+ cells isolated from cord blood with shRNAs and
cultured them in erythroid culture medium. On day nine after
isolation, we compared the levels of LC3-II/actin with cells that
were not infected (NI), infected with a control shRNA (shScr), or
infected with shRNAs against RPS19 (shRPS19). Figure 1H shows
that the successful knock down of RPS19 is coupled to an increase
of the ratio of LC3-II/actin, suggesting an increase in autophagy
as a result of RP knock down in CD34
+ erythroid progenitor cells.
Figure 1. Knock down of RPS19 induces autophagy. (A) Western blot analysis of RPS19 expression in GFP-LC3 HEK cells transfected with siScr or
siRPS19 and either untreated or treated with 100 nM rapamycin overnight (B). Densitometer analysis of the ratio of RPS19 to actin expression from
Fig. 1A. (C) Western blot analysis of LC3 expression in GFP-LC3 HEK cells transfected with siScr or siRPS19 either untreated or treated with 100 nM
rapamycin overnight. (D) Confocal analysis of GFP-LC3 HEK cells transfected with siScr or siRPS19 and either untreated or treated with 50 nM
bafilomycin A for 4 hours. Size bars=10 mM. (E) Quantification of the number of GFP-LC3 puncta per cell from Fig. 1D. At least 8 shots from 3
independent transfections are quantified. (F) Quantification of the percent of cells in Fig. 1D with cytoplasmic GFP-LC3. (G) Representative electron
micrographs of GFP-LC3 HEK cells transfected with siRPS19 and immunogold labeled with LC3 antibodies. Size bar on left panel=500 nM, on right
panel=200 nM. (H) Western blot analysis of LC3 expression in CD34
+ cells either not infected (NI), infected with a scrambled control (shScr) or
infected with a shRNA against RPS19 (shRPS19).
doi:10.1371/journal.pgen.1004371.g001
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Another method that allows for visualization of autophagosome
formation is immunofluorescence (IF) with antibodies against LC3
[35]. We thus performed confocal IF analysis using lymphoblas-
toid cell lines (LCLs) derived from DBA patients carrying
mutations causing haploinsufficiency of RPS17, RPL11,o rRPS7.
These IF experiments, illustrated in Figure 2A, reveal distinct
puncta representative of LC3-II incorporation into developing
autophagosomes and autolysosomes in all three DBA-derived
LCLs compared to very few puncta detected in normal cells
(quantified in Figure 2B, N.100, p,0.01). Additional evidence of
increased autophagy in DBA LCLs is provided by western blot
analysis revealing an increase in LC3-II/actin ratio in the RP
haploinsufficient cells (Figure 2C). The p62 (sequestosome-1/
SQSTM1) protein is a major substrate for autophagy that
becomes degraded upon increased autophagy [36]. Figure 2D
shows a decrease in p62 protein levels by western blot analysis in
DBA-derived LCLs compared to normal control cells, 3 indepen-
dent experiments of which are quantified in Figure 2E. A
significant decrease of p62 is also detected by IF in cells derived
from DBA patients, which is highly significant when the total
amount of p62 expression per cell area is measured (N.100, p,
0.01) (Figures 2F-G). Lastly, electron micrographs in Figure 2H
reveal the presence of many autolysosomes in the RPS17
+/- mutant
cells compared to only small lysosomes in the normal control cells.
Together, these data indicate that mutation of the RP genes in cell
lines derived from DBA patients have increased levels of
autophagy.
Reduction of rpS7 to haploinsufficient levels in zebrafish
embryos induces autophagy in RBCs
The zebrafish lines we selected to study carry viral inserts in the
introns of RP genes that, coupled to the gradual loss of maternally
contributed RPs, result in a progressive decrease of RP expression
[37]. Although eventually lethal to the embryos, we emphasize
that homozygosity of these inserts is synonymous with knock down
models of RP gene loss (the only animal models that faithfully
recapitulate the anemia phenotype of DBA [38–40]) and not
deletion mutants (hereafter referred to as RP-deficient embryos).
Figure 3A illustrates this using western blot analysis of rpS7
expression in wild type or rpS7-deficient embryos at 1 and 2 days
post fertilization (dpf). When normalized to actin, rpS7 expression
at 1 dpf in the rpS7-deficient embryos is ,57% 65 (N=3) of the
expression level in wild type embryos. By 2 dpf, this drops to less
than 5%. We therefore examined the red blood cells (RBCs) at
1 dpf, when rpS7 levels in the mutant embryos are characteristic
of RPS7 haploinsufficiency seen in DBA patients [3].
Figure 3B shows representative electron micrographs of
zebrafish RBCs at 1 dpf (which retain their nuclei, unlike human
RBCs). The upper left panel is a RBC from a wild type embryo
showing mildly condensed chromatin in the nucleus and uniformly
distributed, unadulterated cytoplasm. In contrast, the cytoplasm of
rpS7-deficient mutant RBCs is mottled with circular double-
membrane circular structures, a characteristic feature of autopha-
gosomes (arrowheads in Figure 3B lower left panel, upper right
panel, and highlighted in the lower right panel). Additionally,
autolysosomes are visible in these mutant RBCs (Figure 3B, small
arrows in lower left panel). While small double-membrane
structures are occasionally observed in 1 dpf wild type RBCs,
they appear much more frequently in the mutant embryos, as
quantified in Figure 3C. By 2 dpf the majority of the RBCs in
rpS7-deficient embryos have disappeared, evident by staining the
embryos for hemoglobin with o-dianisidine in Figure 3D. The
results are quantified in Figure 3E by scoring each embryo in the
total clutch as either ‘‘Normal’’, ‘‘Mild’’, or ‘‘Severe’’ depending
on the level hemoglobin loss, followed by genotyping of the
individual embryos to confirm true homozygotes. Despite the loss
of RBCs in 2 dpf embryos, electron microscopic analysis of rpS7-
deficient embryos reveals the presence of characteristic double-
membrane structures in other tissues at this stage. These structures
originating from both the mitochondria (Figure 3F, upper right
panel) and Golgi apparatus (Figure 3F, lower right panel) are
shown engulfing cytoplasmic material. Representative images of
these organelles in wild type embryos are shown in the left panels
of Figure 3F. The mitochondrial structures we visualize in the
rpS7-deficient embryos very closely resemble the previously
reported mitochondria that supply membranes for autophago-
somes in starved mammalian cells [41], and the circular
mitochondria that are formed in response to mitochondrial
oxidative damage [42].
RP loss increases phospo-S6 kinase signaling
It has been previously reported that the knock down of rpS19 or
rpS14 in zebrafish embryos using morpholino oligonucleotides
increases phosphorylation of S6 kinase [43]. In agreement with
these previous results, we detect an increase in p70 phospho-S6
kinase signaling at Thr389 in the GFP-LC3 HEK cells transfected
with the siRNAs against RPS19 compared to siScr, a signal that is
completely abolished by the addition of rapamycin (Figure 4A).
Given that rapamycin is well known to directly inhibit TOR, this
suggests that TOR is likely phosphorylating S6 kinase in this
model. An increase in phosphorylation of S6 kinase is also
observed upon knock down of RPS19 in CD34
+ cells (Figure 4B).
We additionally detect an increase in phospho-S6 kinase signaling
in the LCLs with haploinsufficient RP gene mutations, including
an increase in p85 S6 kinase phosphorylation (Figure 4C). Similar
to human cells with RP loss or mutations, we observe a large
increase in S6 kinase phosphorylation in our genetic models of RP
deficiency (Figure 4D). Unfortunately, despite several attempts we
were unable to find a commercially available S6 kinase antibody
that cross-reacted with zebrafish. However, given the strength of
the S6 kinase phosphorylation signal and the normal expression of
actin, we are confident that this increase is not due to a large
increase in S6 kinase expression. Taken together, these results
demonstrate that the loss or mutation of several RPs in both
human and zebrafish cells results in an increase of S6 kinase
phosphorylation.
RP loss results in a decrease of IRS1 and phosphorylated
AKT substrates
Overactive S6 kinase phosphorylation causes the inhibition of
the insulin pathway, in which AKT plays a central role [27,28].
One known mechanism of this inhibition is through a direct
phosphorylation step of IRS1 by S6 kinase that in turn targets
IRS1 for degradation [28]. To determine if RP loss affects
downstream mediators of the insulin pathway, we performed
western blot analysis on cells with reduced RPs to measure levels of
IRS1 and phosphorylated AKT substrates. A decrease of IRS1 is
observed in siScr transfected GFP-LC3 HEK cells when stimu-
lated with insulin for 6 hours, similar to what has been shown
previously in adipocytes treated with insulin over time [44]
(Figure 5A). We also observe by densitometer analysis an ,50%
decrease in IRS1 expression in cells transfected with siRPS19
compared to siScr, suggesting that the increase in S6 kinase
phosphorylation observed in the siRPS19 cells results in degrada-
tion of IRS1. To determine the effect of RP loss on AKT activity,
we performed western blotting with an antibody that recognizes
the phosphorylation motif of AKT substrates, (RXXS*/T*).
Ribosome Impairments and Autophagy
PLOS Genetics | www.plosgenetics.org 4 May 2014 | Volume 10 | Issue 5 | e1004371Figure 2. DBA mutations induce autophagy. (A) Immunofluorescence with LC3 antibodies in LCLs derived from a normal control or DBA
patients. Higher magnifications are represented in the lower panel. Arrows denote puncta indicative of LC3 recruitment to autophagosomes, or
accumulation in autolysosomes. Size bars=10 mM. (B) Quantification of the percent of cells revealing LC3 puncta compared to the total number of
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of phosphorylated AKT substrates compared to siScr, while
treatment with insulin had the expected effect of increasing the
AKT substrate phosphorylation in cells transfected with either
siRNA (Figures 5B-C). Similarly, western blot analysis of several
different RP-deficient zebrafish embryos reveals a substantial
decrease in the phosphorylation of AKT substrates (Figure 5D).
Taken together the data suggest that RP loss results in inhibition of
AKT phosphorylation activity, likely driven by the degradation of
IRS1.
Insulin abolishes autophagy in cells with RPS19 loss
In order to determine if activation of the insulin pathway could
override the signals inducing autophagy in models of RP loss, we
treated siRNA-transfected GFP-LC3 HEK cells with 350 nM
insulin and performed confocal analysis and western blotting.
Figures 6A-B show that the addition of insulin significantly
reduced the number of GFP-LC3 puncta in the siRPS19-
transfected cells to the same levels as siScr cells (N.100, p,
0.01). This reduction of autophagy is also revealed in the LC3
western blots shown in Figure 6C, where the increase of LC3II/
actin ratio in the siRPS19 cells is reduced upon insulin stimulation
to the ratio observed in the cells transfected with siScr. When we
performed a titration of insulin on LC3-GFP HEK cells
transfected with siRNAs against RPS19 we found that as little as
10 nM insulin was sufficient to significantly reduce the number of
autophagosomes compared to untreated cells (Supporting Figure
S1). We therefore conclude that the down-regulation of insulin
pathway signaling, evident in the data presented in Figure 5, is
coupled to the induction of autophagy by RP loss.
S6 kinase signaling, autophagy, and p53 stabilization are
linked to increased reactive oxygen species (ROS)
The rapamycin experiment in Figure 4A shows that the
increased phosphorylation of S6 kinase linked to RP loss is
dependent on TOR. Given the mitochondrial modifications
revealed by electron microscopy, we hypothesized that one
potential mechanism for this activation may be linked to the
TOR function of sensing abnormal levels of intracellular ROS
[45]. Trolox, a vitamin E derivative, functions as an anti-oxidant
by the intracellular scavenging of ROS [46]. The addition of
Trolox to GFP-LC3 HEK cells resulted in a significant reduction
in the number of autophagosomes, abolishing the basal level
observed in siScr-transfected cells and diminishing the abnormally
high level observed in the siRPS19 cells (N.100, p,0.02)
(Figures 7A-B). This reduction of autophagy is coupled to a
decrease in the phosphorylation of S6 kinase, shown by western
blot analysis in Figure 7C. Moreover, when we treated RP-
deficient zebrafish embryos with 10 mM Trolox overnight we
observed a substantial decrease in the levels of S6 kinase
phosphorylation in embryos carrying mutations in rpS7 or rpS3a,
which in turn alleviated the inhibition of AKT phosphorylation
activity (Figure 7D). Interestingly, the Trolox treatment while
clearly blocking autophagosome formation in the GFP-LC3 HEK
cells was unexpectedly coupled to an increase of LC3-II by western
blotting analysis (Supporting Figure S2), the latter a feature of
Trolox that has been previously reported [47]. However, in the
same cells we also find that Trolox results in an increase of p62
expression and a decrease of phosphorylated S6 kinase, supporting
the confocal results indicating that there is a block of autophagy
due to a reduction of S6 kinase signaling (Supporting Figure S2).
The wild type and rpL11 embryos are not represented in
Figure 7D because they do not survive the 10 mM Trolox
treatment. This is compared to a survival rate of over 80% of the
rpS3a embryos and ,40% of the rpS7 embryos (Figure 7E).
Interestingly, these survival rates correlate with the severity of the
morphological phenotypes typically observed with RP mutants
including smaller heads/eyes, inflated hindbrain ventricles, and
the presence of pericardial edemas [48]. Embryos are morpho-
logically affected most acutely by the rpS3a mutation, followed by
the rpS7 mutation, while the rpL11 mutation is comparatively
milder (Supporting Figure S3A). In other words, the increased
survival of the rpS3a and rpS7 deficient mutants upon the Trolox
treatment is likely due to the their higher initial ROS levels
compared to wild type or rpL11 deficient mutants. This is
illustrated in Supporting Figure S3B.
Many cellular stresses, including oxidative damage and ROS,
result in stabilization of the p53 tumor suppressor and the
induction of apoptosis [49]. In zebrafish embryos, a homozygous
mutation in the DNA binding domain of the p53 gene (M214K)
allows for an intensified and sustained stabilization of p53 in
response to stress [50,51]. We therefore crossed the rpS7-deficient
embryos with the p53 mutant background in order to enhance p53
detection by western blotting (Figure 7F). These double mutant
embryos treated with 100 mM of Trolox overnight revealed a
considerable reduction of the level of p53 stabilization (Figure 7G).
These data suggest that the phosphorylation of S6 kinase, the
inhibition of AKT activity, the subsequent induction of autophagy,
and the stabilization of p53 due to RP loss are due to an increase
of intracellular ROS. This is represented by a graphic illustration
in Figure 8.
Autophagy is not unique to RP gene-linked
ribosomopathies
Our study so far focuses on DBA-linked RP gene mutations,
however deregulated autophagy may be a more general phenotype
of ribosomopathies. To explore this possibility we examined cells
derived from SDS patients, most of which carry a mutation in the
SBDS gene that is important for one of the final maturation steps of
the 60S ribosomal subunit [52,53]. Primary mononuclear cells
(MNCs) isolated from the peripheral blood of two independent
SDS patients revealed an increase in expression of LC3-II to actin
compared to MNCs from a healthy individual (Figure 9A).
Moreover, we found evidence of increased autophagy in non-
hematopoietic primary fibroblasts derived from four other
independent SDS patients. Figures 9B-D illustrate with confocal
and western blot analysis that levels of the autophagy substrate p62
are substantially diminished in cultured fibroblasts derived from
SDS patients compared to those from a healthy individual. Taken
all together, the data suggest that the deregulation of autophagy is
cells in the 60x shots. (C) Western blot analysis of LC3 in DBA LCLs compared to normal controls. The LC3II/actin ratio is determined by densitometer
analysis. (D) Representative western blot analysis of p62 levels in normal control and DBA patient LCLs. (E) Densitometer analysis of p62 protein
expression from western blots (N=3) represented in (D). (F) Immunofluorescence with p62 antibodies of LCLs derived from a normal control or DBA
patients. Size bars=10 mM. (G) ImageJ measurements of p62 expression in (F) per total cell area. (H) Representative electron micrographs of LCLs
derived from a normal control and RPS17 cells. Control cells have small typically dense lysosomes (*). The much larger autolysosomes (A) are only
detected in RPS17 LCLs. The boxed area in the upper right panel is shown at higher magnification in the lower right panel. N=nucleus,
ECS=extracellular space. Bars in top panels=1 mM, bottom panels=200 nM.
doi:10.1371/journal.pgen.1004371.g002
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PLOS Genetics | www.plosgenetics.org 6 May 2014 | Volume 10 | Issue 5 | e1004371Figure 3. Reduction of rpS7 to haploinsufficient levels in zebrafish embryos induces autophagy in RBCs. (A) Western blot analysis of
rpS7 protein levels in zebrafish carrying viral inserts in the rpS7 gene at 1 and 2 dpf. The amount of rpS7 is calculated by densitometer analysis
measuring the rpS7/actin ratio (N=3). (B) Electron micrographs of 1 dpf embryos. Representative morphology of RBCs is shown in wild type (upper
left panel) and rpS7-deficient embryos (upper right and lower panels). Arrowheads indicate double-membrane autophagosomes, arrows indicate
autolysosomes. N=nucleus. Size bars upper and bottom left panels=1 mM, upper right=500 nM, lower right=200 nM. (C) Quantification of double-
membrane structures in the RBCs of micrographs in (B). In each case 28 cells were examined. (D) O-dianisidine staining of embryos at 2 dpf. Embryos
(N.100) were scored in (E) and genotyped to confirm mutation status. (F) Representative mitochondrial morphology (m) displayed in wild type
(upper left panel) and rpS7-deficient embryos at 2dpf (upper right). Typical Golgi complex (G) in wild type embryos shown (lower left panel)
compared to Golgi complex in rpS7-deficient embryos (lower right). Arrows denote double membranes sequestering cytosolic material, an indication
for autophagosome formation. *Denotes engulfed cytoplasmic material. Size bars=200 nM.
doi:10.1371/journal.pgen.1004371.g003
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marrow failure. Moreover, given that the majority of the
experiments were performed in non-erythroid cells, they suggest
a general relevance of autophagy and inhibition of the insulin
pathway that likely extends beyond the cytopenia phenotype of
ribosomopathies.
Discussion
This study demonstrates conclusively that mutations in RP
genes induce autophagy through ROS-mediated S6 kinase
phosphorylation. Other animal models, including Drosophila and
zebrafish, have shown previously that different mutations affecting
the processing of rRNA induce autophagy, however the mecha-
nisms have remained incompletely understood [54,55]. The study
of the zebrafish defective in rRNA processing by mutation of
pwp2h suggests that the mechanism is likely p53- and TOR-
independent, despite the fact that the authors also note in their
mutants an increase in phosphorylation of rpS6 (a substrate of S6
kinase downstream of TOR) [55]. The loss of RPs in zebrafish and
mouse models of DBA has also been recently linked to major
changes in metabolism, particularly glycolysis [40]. We therefore
speculated that a link exists between the autophagy induced by
mutations affecting the ribosome and the insulin pathway.
Similar to other zebrafish models of RP loss using morpholinos
[56], we observe an increase in phosphorylation of S6 kinase in
our genetic RP-deficient zebrafish embryos and in human cells
with RP loss which is dependent on TOR and independent of
AKT. Since reducing ROS levels with the antioxidant Trolox
decreases this S6 kinase phosphorylation and reduces the
autophagy activated by RP loss, we propose that increasing
ROS levels is the link between RP loss and S6 kinase
phosphorylation by TOR. This relationship between ROS,
TOR, and S6 kinase has been previously reported as the result
of nutrient overload, raising the likelihood that metabolic stress
sensed by mitochondria is communicated to the TOR pathway
directly through ROS [28,45].
ROS is increasingly becoming recognized as a critical signaling
molecule and not just a damaging agent [57]. Our data underscore
this by showing the importance of maintaining ROS levels at a
particular threshold during the developmental process, and how
reducing this threshold with Trolox is lethal to wild type, but not
RP-deficient embryos with severe morphological phenotypes.
Interestingly, other recent reports are beginning to reveal links
between different inherited bone marrow failure disorders with
increasing levels of intracellular ROS including DC, SDS, and
Fanconi anemia [58–60]. These reports along with our study raise
the possibility that the phenotypes of these bone marrow failure
disorders may share a common basis that is increased ROS
released from stressed mitochondria. Our study goes on to suggest
that the stabilization of p53, long regarded as the mechanism
behind the early death of erythroid progenitor cells in DBA patient
bone marrow, is also triggered by increasing ROS. Since
hematopoietic progenitor cell death in Fanconi anemia has been
definitively linked to p53 stabilization [61], our results suggest a
general mechanism of cell death induced by ROS may underlie
these congenital bone marrow failures.
The increase in S6 kinase phosphorylation that we observe
upon RP loss is coupled to a decrease in the phosphorylation of
AKT substrates, suggesting a mechanism similar to the over
activation of S6 kinase promoting insulin resistance. The study
mentioned previously is in line with this showing rpL11
-/- zebrafish
embryos and whole blood of rpL11
+/- adult fish contain higher
levels of glucose compared to wild type controls, an accumulation
Figure 4. RP loss increases phospo-S6 kinase signaling. (A) Western blot analysis showing the expression of phosphorylated S6 kinase in GFP-
LC3 HEK cells transfected with siScr or siRPS19 and either untreated or treated with 100 nM rapamycin overnight. (B) Western blot analysis of
phosphorylated S6 kinase expression in CD34
+ cord blood cells infected with a control shRNA (shScr) or an shRNA against RPS19 (shRPS19). (C)
Western blot analysis of phosphorylated S6 kinase expression in LCLs derived from a normal control or DBA patients. (D) Western blot analysis of
phosphorylated S6 kinase expression in 2 dpf zebrafish embryos.
doi:10.1371/journal.pgen.1004371.g004
Ribosome Impairments and Autophagy
PLOS Genetics | www.plosgenetics.org 8 May 2014 | Volume 10 | Issue 5 | e1004371that would be expected if cells are unable to import and
metabolize glucose properly [40]. This same study also measured
a decrease of glycolytic enzymes in the rpL11
-/- embryos and in
fetal mouse liver cells with knocked down Rps19 [40]. It has been
reported that insulin signaling is important for the proliferation of
late erythroblasts and that impaired insulin signaling can cause
severe growth defects in animal models [62–64]. Therefore insulin
pathway inhibition may provide an additional layer of regulation
underlying the cytopenia phenotypes, and suggests a putative
mechanism of the growth defect phenotypes that are both present
in DBA and common to other ribosomopathies.
The conflicting results regarding the Trolox treatment in
Supporting Figure S2 are worth noting. As mentioned, the
increase of LC3-II that we observe with western blotting analysis
despite a clear block of autophagosome formation has been
previously reported in cells treated with Trolox, but the results in
this report are in the absence of any confocal or IF data showing
LC3 localization [47]. Consistent with our results it has been
reported that many other antioxidants block autophagy [65].
Therefore it appears antioxidants inhibit autophagosome
formation while simultaneously increasing LC3-II accumulation.
These data underscore the limitations of using LC3 western
blotting as the sole readout of autophagy activity, and highlight the
importance of performing concurrent LC3 localization experi-
ments.
Our study describes how the impairment of insulin signaling
and deregulation of autophagy result from mutations of RPs.
Moreover, we demonstrate that these pathways may be involved in
the etiology of a broader range of ribosomopathies that are linked
to other mutations affecting the ribosome. While it seems clear
that increased levels of ROS as a result of these mutations induces
deregulation of autophagy, insulin signaling, and activation of the
p53, it is of course difficult to conclusively state the contribution of
each impairment to the early death of hematopoietic cells in
ribosomopathy patients. Most likely this early death is a
combination of all these and other deregulated pathways.
Nonetheless, our study suggests that therapeutics targeting
intracellular ROS levels may be an effective treatment for patients
with bone marrow failures that are linked to mutations affecting
the ribosome.
Figure 5. RP loss results in a decrease of IRS1 and phosphorylated AKT substrates. (A) Western blot analysis of IRS1 in GFP-LC3 HEK cells
transfected with siScr or siRPS19.( B) Western blot analysis of phosphorylated AKT substrates in GFP-LC3 HEK cells transfected with siScr or siRPS19
and either untreated or stimulated with 350 nM insulin for 6 hours. (C) Densitometer analysis of the total expression level of phosphorylated AKT
substrates in (B). (D) Western blot analysis of phosphorylated AKT substrates in 2 dpf zebrafish embryos.
doi:10.1371/journal.pgen.1004371.g005
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Ethics statement
Animal experiments were conducted in accordance with the
Dutch guidelines for the care and use of laboratory animals, with
the approval of the Animal Experimentation Committee (Dier
Experimenten Commissie [DEC]) of the Royal Netherlands
Academy of Arts and Sciences (Koninklijke Nederlandse Akade-
mie van Wetenschappen [KNAW] (Protocol # 08.2001).
Fish maintenance
Zebrafish were raised and embryos obtained through natural
spawning as previously described (Westerfield, The Zebrafish
Book. A Guide for the Laboratory Use of Zebrafish, 3rd Edition,
1995) in accordance with all Dutch regulations and guidelines.
Cell lines
The GFP-LC3 HEK cells were a kind gift from Dr. Paul
Coffer’s lab. For the lymphoblastoid cell lines (LCLs), RPS17 cells
carry a deletion in exon 3 (c.200_201delGA) resulting in a
frameshift at codon 67 and an early stop codon at 86. RPL11 cells
carry an insert in exon 3 (c.160_161insA) resulting in a frameshift
at codon 54 and an early stop at codon 66. RPS7 cells carry a
donor splice site mutation in intron 3 (IVS3+1g .a). SDS MNCs
were obtained by blood samples collected in a heparin vacutainer,
diluted 1:1 in PBS, layered over half the total volume of Ficoll (GE
Healthcare) and centrifuged at 287 RCF for 20 min. The MNC
and monocyte layer was then removed and washed 2x in 1xPBS.
Cell lines were incubated at 37uC +5% CO2, the LCLs in RPMI
medium +10% FCS +1% pen/strep and fibroblasts in DMEM
media +10% FCS +1% pen/strep. All primary cells and patient-
derived cell lines used in this study were from patients and families
that gave informed consent according to the Declaration of
Helsinki.
siRNA knock downs
siRNAs against RPS19 were purchased from Invitrogen
(#4392420). ‘‘Stealth RNAi’’ scrambled siRNAs from Invitrogen
were used as a control (#12935-400). GFP-LC3 HEK cells were
plated in 24-well plates (or on glass-bottom confocal dishes,
Greiner Bio-One GmbH, #627870) the day before transfection
with DMEM media. Transfections were done with Oligofectamine
(Invitrogen, #12252-011) according to the manufacturer’s in-
structions using the maximum recommended amount of siRNAs.
Bafilomycin A (Sigma, #B1793) was added at a final concentra-
tion of 50 nM for 4 hours. Rapamycin (Sigma, #R8781) was
added at a final concentration of 100 nM for 6 hours. 10 mM of
Trolox (Sigma #238813) was added overnight. Insulin (Sigma,
#I6634) was added at a final concentration of 350 nM for
6 hours. Confocal analysis was performed on a Leica SPE
microscope. At least 8 shots per transfection were taken, and at
least 3 transfections per condition were performed. The counter in
Figure 6. Insulin abolishes autophagy in cells with RPS19 loss. (A) Confocal microscopy analysis of GFP-LC3 HEK cells transfected with siScr or
siRPS19 and either untreated or stimulated with 350 nM insulin for 6 hours. Size bars=10 mM. (B) Quantification of the average number of GFP-LC3
puncta per cell in (A). (C) Western blot analysis of LC3 expression in cells from (A). Densitometer analysis used to calculate the ratio of LC3II/actin.
doi:10.1371/journal.pgen.1004371.g006
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PLOS Genetics | www.plosgenetics.org 10 May 2014 | Volume 10 | Issue 5 | e1004371Figure 7. S6 kinase phosphorylation and autophagy is induced by reactive oxygen species (ROS). (A) Confocal microscopy analysis of
GFP-LC3 HEK cells transfected with siScr or siRPS19 and either untreated or treated with 10 mM Trolox overnight. Size bars=10 mM. (B) Quantification
of the average number of GFP-LC3 puncta per cell in (A). (C) Western blot analysis of phosphorylated S6 kinase expression in GFP-LC3 HEK
transfected with siScr or siRPS19 and either untreated or treated with 10 mM Trolox overnight. (D) Western blot analysis of phosphorylated S6 kinase
and phosphorylated AKT substrate expression in 2 dpf zebrafish embryos untreated or treated with 10 mM Trolox overnight. (E) Survival rates of
embryos treated overnight with 10 mM Trolox. The results are the compilation of three independent experiments with N=25 embryos representing
each mutation. The statistics shown are compared to wild type. (F) Analysis of p53 stabilization in 2 dpf wild type, rpS7-deficient embryos,
p53
M214K/M214K mutant embryos, or double mutants (rpS7;p53) by western blotting. (G) Analysis of p53 stabilization by western blotting of zebrafish
mutants treated overnight with 100 mM Trolox.
doi:10.1371/journal.pgen.1004371.g007
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number of cells with cytoplasmic GFP (the images were unlabeled
to prevent bias).
Western blot analysis
Zebrafish embryos were lysed as previously described [66].
Trolox was added to embryos in E3 media overnight at 10 mM.
LCLs and fibroblasts were lysed on ice using 1% Triton X-100
buffer containing protease and phosphatase inhibitor tablets
(Roche) and normalized to 25 mgp e rs a m p l e .L y s a t e sw e r e
loaded and fractionated by SDS-PAGE (8% for IRS1 and
pAKT substrates; 10% gels for p62, pS6 kinase, and S6 kinase;
and 12% for LC3 and RPS19) under reducing conditions and
immunoblotted on PVDF membranes. Primary antibodies used
were RPS7 (Santa Cruz #sc-100834) at a dilution of 1:250,
RPS19 (Santa Cruz #sc-100836) at 1:1000, LC3 for LCLs at
2 mg/ml (Novus Biologicals #NB100-2331), LC3 for MNCs,
HEK and CD34+ cells at 1:1000 (Millipore #ABC232),
phospho-S6 kinase (Cell Signaling #92345) at 1:1000, S6
kinase (Cell Signaling #92025), p62 at 1:1000 (Progen #GP62-
C), and actin antibodies (Santa Cruz #sc-1616) at 1:200. The
zebrafish-specific p53 antibody (zp53) was raised as previously
described [66]. Secondary antibodies were diluted 1:5000
including rabbit-HRP (GE Healthcare) for LC3, pS6 kinase,
and S6, mouse-HRP (GE Healthcare) for RPS7, RPS19, and
zp53 blots, guinea pig-HRP (Abcam #ab97155) for p62, and
goat-HRP (Santa Cruz #sc-2020) for actin blots. ECL reagent
(Amersham Biosciences) was used for detection either with
Kodak Biomax XAR film or with ImageQuant LAS 4000 (GE
Healthcare). Densitometer analysis was performed using a GS-
800 densitometer (BioRad) and Quantity One software
(BioRad).
Survival curve
Embryos were left in their chorions and treated with 10 mM
Trolox in E3 media overnight. The survival of the embryos was
assessed by the presence of a heartbeat.
Electron microscopy
For electron microscopy analysis, LCLs, GFP-LC3 HEK cells,
and 1 and 2 dpf zebrafish embryos were fixed in a mixture of 2%
paraformaldehyde and 0.2% glutaraldehyde in 0.1 M phosphate
buffer. The cells or embryos were washed in PBS-glycine to
quench free aldehydes, then embedded in gelatin and infiltrated in
2.3 M sucrose, followed by rapid freezing in liquid N2.5 0n M
thick cryosections were cut at 2120uC using an Ultracut-S ultra
Figure 8. Graphic representation of how RP mutations result in autophagy and insulin pathway inhibition. In normal cells, insulin
signals through the insulin receptor substrate (IRS) to the PI3-kinase/AKT pathway in a manner that inhibits autophagy and increases the expression
of glucose transporters on the cell membrane. In cells with RP loss, an increase of ROS stabilizes p53 and induces phosphorylation of S6 kinase. This
hyper-phosphorylation of S6 kinase results in degradation of IRS and a decrease of insulin signaling to PI3-kinase and AKT. This loss of AKT activation
in turn releases the inhibition of autophagy and reduces glycolysis.
doi:10.1371/journal.pgen.1004371.g008
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either directly viewed in a JEOL 1200CX electron microscope
(Jeol Ltd. Japan), or after immuno-gold labeling with rabbit anti-
LC3B (Abgent, #AP1805a or AP1806a, Oxfordshire UK),
followed by 10 nm protein-A gold.
Immunofluorescence
For LCLs, Shandon cytospins (5 min at 35 RCF) were used to
place cells on 12 mm coverslips (VWR), cells were then fixed and
permeabilized with methanol-acetone (1:1 volume). Fibroblasts
were grown overnight in DMEM +10% FCS +1% pen/strep on
coverslips, then fixed as above. Primary PBMCs were initially
fixed in 2% paraformaldehyde in PBS, then placed on coverslips
with Shandon cytospins and permeabilized with 0.1% Triton X-
100. Cells were blocked with PBS and 0.2% fish skin gelatin
(Sigma) at RT twice for 10 min each. All antibodies were diluted
in this blocking buffer. Primary antibodies against LC3B (Abgent,
Oxfordshire UK) were diluted 1:100 and p62 (Progen) at 1:300,
then added to the blocked cells for 30 min at RT. Secondary
antibodies GaR-Alexa488 (against LC3B, Invitrogen) and DkaGP-
Alexa488 (against p62, Biotium) were all diluted 1:100 and
incubated on the cells in the dark for 30 min at RT. Cells were
mounted in Prolong Gold + DAPI (Invitrogen). Subcellular
distribution patterns were analyzed using a Zeiss LSM-510
confocal microscope. Individuals counting the number of cells in
each confocal slice that displayed the LC3-positive puncta carried
out quantifications of the puncta staining. Average numbers were
displayed as a percentage of the total number of cells per image
(unlabeled images were used to prevent bias). For p62 quantifi-
cation ImageJ software was used to calculate the total amount of
p62 staining per total number of cells using the following
parameters: File=8 bits, threshold=40–255, size=0–infinity,
and circularity=0.00–1.00.
Erythroid cell culture
CD34
+ cells were isolated from cord blood using the
immunomagnetic technique (Miltenyi Biotec, Paris, France).
CD34
+ cells were cultured for two days in presence of 10%
FBS, 100 U/ml IL-3, 10 ng/ml IL-6, 25 ng/ml SCF, 10 ng/ml
TPO, and 10 ng/ml Flt3-L. A first infection with shRNA-RPS19
compared to non-infected cells or shRNA-Scr infection (all the
shRNA generation and lentiviral production is previously
described [67]) was then performed at a 50 MOI. For shRNA-
RPS19C, a second infection was performed 6 hours after the
first infection. Cells were cultured for two more days and GFP-
positive cells were sorted using the FACSDIVA Cell Sorter.
Sorted cells were switched to the same IMDM medium
with SCF (50 ng/ml), IL3 (1 U/ml) and EPO at 1 U/ml
till D7 when the FBS concentration was increased to 30%
(from D7 to D14). Pellets of 100,000 cells were frozen until
lysing.
O-dianisidine staining
O-dianisidine staining was performed on 2 dpf embryos as
previously described [68]. The genotypes of embryos were
verified in a 3-primer PCR reaction: 59-CTCTTGGAT-
GGCTTGGACATGC-39,5 9- CACTATTTTCGCGCTGGTA-
CTGAAC-39 (which paired give a 570 bp band with wild
type gDNA) and a primer that anneals to the viral insert
nLTR3, 59-CTGTTCCATCTGTTCCTGAC-39 which yields a
275 bp band in the presence of the viral insertion in the rpS7
gene.
Figure 9. Cells from SDS patients reveal increased autophagy. (A) Western blot analysis of LC3 in primary MNCs isolated from two
independent SDS patient peripheral blood. (B) Western blot analysis of p62 levels in primary fibroblasts isolated from four independent SDS patients.
(C) Confocal analysis of p62 levels in SDS fibroblasts, quantified in (D). At least 8 shots from 3 independent experiments are quantified.
doi:10.1371/journal.pgen.1004371.g009
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Statistics in all experiments were performed using the Student’s
two-tailed t-test.
Supporting Information
Figure S1 (A) Confocal analysis of LC3-GFP expressing HEK
cells transfected with siRNAs against RPS19 and either untreated
(upper left) or treated overnight with 10, 50, or 100nM insulin. (B)
Quantification of the number of LC3-GFP positive puncta per
cell. **p,0.01.
(PDF)
Figure S2 Representative western blot analysis of GFP-LC3
HEK cells transfected with siRNAs against RPS19 or a scrambled
control (siScr) and blotted with antibodies against LC3, p62,
pS6 kinase (pS6K), S6 kinase, (S6K) or actin. The ratio of
LC3-II to actin expression is calculated using densitometer
measurements.
(PDF)
Figure S3 (A) Representative gross morphology of wild type
embryos compared to those homozygous for viral inserts in the
rpS3a, rpS7,o rrpL11 genes. Arrowheads indicate hindbrain
ventricle inflation, arrows indicate pericardial edemas. All
embryos shown are at 2 dpf. (B) Diagram illustrating how the
increased ROS levels caused by rpS3a and rpS7 mutations act to
protect the embryos against the lethality caused by long-term
exposure to the antioxidant Trolox.
(PDF)
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